Details for New Drug Application (NDA): 213229
✉ Email this page to a colleague
NDA 213229 describes SUCCINYLCHOLINE CHLORIDE, which is a drug marketed by Accord Hlthcare, Amneal, Amphastar Pharms Inc, Amring Pharms, Aspiro, Baxter Hlthcare Corp, Be Pharms, Breckenridge, Deva Holding As, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Intl Medication, Mankind Pharma, Meitheal, Micro Labs, Nexus, Organon Usa Inc, Regcon Holdings, Sagent Pharms Inc, Somerset Theraps Llc, Umedica, Zydus Pharms, and Steriscience, and is included in thirty NDAs. It is available from twenty-eight suppliers. There is one patent protecting this drug. Additional details are available on the SUCCINYLCHOLINE CHLORIDE profile page.
The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Summary for 213229
| Tradename: | SUCCINYLCHOLINE CHLORIDE |
| Applicant: | Hikma |
| Ingredient: | succinylcholine chloride |
| Patents: | 0 |
Pharmacology for NDA: 213229
| Physiological Effect | Neuromuscular Depolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 213229
Suppliers and Packaging for NDA: 213229
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 213229 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9338 | 0143-9338-25 | 25 VIAL in 1 CARTON (0143-9338-25) / 10 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
| Approval Date: | Jun 12, 2020 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
